ENGN – engene holdings inc. (US:NASDAQ)
Stock Stats
News
enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting [Yahoo! Finance]
enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
enGene Holdings Inc. (NASDAQ: ENGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $34.00 price target on the stock.
engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development
Form 424B3 enGene Holdings Inc.
Form 4 enGene Holdings Inc. For: Apr 18 Filed by: FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
Form ARS enGene Holdings Inc. For: Oct 31
Form DEF 14A enGene Holdings Inc. For: May 15
Form 4 enGene Holdings Inc. For: Mar 21 Filed by: Zoth Lota S.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.